Retinoid chemoprevention in patients at high risk for skin cancer

Medical and Pediatric Oncology
J J DiGiovanna

Abstract

Patients who develop large numbers of skin cancers suffer increased morbidity and mortality. A high skin cancer risk can result from inherited disorders such as xeroderma pigmentosum (abnormal repair of UV-induced DNA damage) or the nevoid basal cell carcinoma syndrome (tumor suppressor gene abnormality). The efficacy of systemic retinoid skin cancer chemoprevention was first demonstrated in these disorders. Since the mechanism of cancer prevention was not thought to involve correction of the underlying defect causing the disorder, individuals at high risk for new skin cancers from other causes may also benefit from this approach. With the success of organ transplantation, there is a growing population of transplant recipients living long, active lives who also have sustained chronic UV damage. This population is at high risk for developing aggressive squamous cell carcinomas. In this population, extensive skin involvement with human papilloma virus induced warts and actinic keratoses results in difficulty with diagnosis and monitoring for these dangerous malignancies. Patients who have received treatment with agents that cause DNA damage, such as X-radiation, may also have a high skin cancer risk. Retinoid chemoprevention may ...Continue Reading

References

Mar 1, 1990·Transplantation·M M HarteveltJ P Vandenbroucke
Jul 1, 1988·Journal of the American Academy of Dermatology·G L PeckF W Yoder
Jun 23, 1988·The New England Journal of Medicine·K H KraemerG L Peck
Nov 1, 1995·Archives of Dermatology·J J DiGiovannaJ C Reynolds
Aug 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J N BavinckB J Vermeer
Aug 14, 1998·Journal of the American Academy of Dermatology·J J DiGiovanna
Jan 28, 1999·Journal of the American Academy of Dermatology·C S OngP M Spratt
May 8, 1999·The British Journal of Dermatology·D B McKenna, G M Murphy

❮ Previous
Next ❯

Citations

Jan 16, 2014·Indian Journal of Otolaryngology and Head and Neck Surgery : Official Publication of the Association of Otolaryngologists of India·Sudhir M NaikSumit Gupta
Apr 6, 2004·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·Y G L De GraafJ N Bouwes Bavinck
Jun 26, 2002·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·Noah Kawika Weisberg, Matthew Varghese
Jul 13, 2014·American Journal of Clinical Dermatology·Lauren BrinJerry D Brewer
Aug 13, 2014·Indian Journal of Surgical Oncology·Rajshekar HalkudSiddharth Biswas
Dec 23, 2003·Best Practice & Research. Clinical Endocrinology & Metabolism·Shelly S Lo, Victor G Vogel
Sep 15, 2006·The Journal of Dermatological Treatment·Gita Faghihi, Mohammadreza Radan
Nov 3, 2010·Clinical & Experimental Ophthalmology·Ann P MurchisonCarl V Washington
Apr 29, 2010·The British Journal of Dermatology·A D OrmerodUNKNOWN BAD Clinical Standards Unit
Jul 29, 2004·Journal of the American Academy of Dermatology·Carla Sanchez-Palacios, Joan Guitart
May 23, 2006·Journal of the American Academy of Dermatology·Tina I WrightFranklin P Flowers
Mar 21, 2002·Nature Reviews. Cancer·L Altucci, H Gronemeyer
Jul 21, 2006·Ophthalmic Plastic and Reconstructive Surgery·Simon F TaylorBrian Leatherbarrow
Sep 26, 2019·Archivum Immunologiae Et Therapiae Experimentalis·Wangqing ChenXiang Chen
Jun 10, 2003·Journal of Radiation Research·Fredric J BurnsMoon-Shong Tang
Dec 21, 2017·Skin Pharmacology and Physiology·Ana R FernandesEliana B Souto

❮ Previous
Next ❯

Related Concepts

Related Feeds

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.